4
Changes in Ownership
Lexaria Bioscience Corp. Filed Acc 0001312326-19-000002
Options or other derivatives
- Director acquired 150,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Baxter Nicholas W Director | 2019-05-06 | Grant or award · Stock Options | +150,000 | $0.99 | $148,500 | 260,000 | D: show line 1 in the form |
Loading xslF345X03/primary_doc.xml…